Skip to main content
. 2022 Nov 22;14(11):e31796. doi: 10.7759/cureus.31796

Table 4. Raw data for meta-analysis on improvement in psychiatric illness with the use of psilocybin.

SE = standard error; CI = confidence interval; ID = identification

Study Events Sample size Outcome SE CI lower CI upper Study ID Rate CI lower CI upper
Carhart-Harris et al. 2016 [26] 19 20 0.95 0.22 0.52 1.34 10 95 42.72 42.72
Carhart-Harris et al. 2017 [17] 19 19 1 0.23 0.55 1.45 9 100 44.97 44.97
Davis et al. 2021 [32] 17 24 0.71 0.17 0.37 1.04 8 70.83 33.67 33.67
Ross et al. 2016 [33] 20.3 29 0.7 0.16 0.39 1.00 7 70 30.45 30.45
Griffiths et al. 2016 [4] 41 51 0.80 0.13 0.56 1.05 6 80.39 24.60 24.61
Larsen et al. 2017 [6] 2 12 0.17 0.12 -0.06 0.39 5 16.67 23.10 23.10
Johnson et al. 2014 [23] 12 15 0.8 0.23 0.35 1.25 4 80 45.26 45.26
Mason et al. 2019 [11] 50 50 1 0.14 0.72 1.28 3 100 27.72 27.72
Stroud et al. 2018 [12] 17 17 1 0.24 0.52 1.48 2 100 47.54 47.54
Summary 197.3 237 0.77 0.11 0.55 0.99 1 76.98 21.68 21.68